Acepodia Funding & Investors

Alameda, CA

Acepodia is using its proprietary bioconjugation technology to develop the next wave of off-the-shelf cell therapies for cancer.

Total Amount Raised: $256,000,000

Acepodia Funding Rounds

Series D
$100,000,000
Jun 5, 2023
Series D Investors
Digital Mobile Venture
Series C
$109,000,000
Dec 1, 2021
Series C Investors
Digital Mobile Venture
Series B
$47,000,000
Mar 15, 2021
Series B Investors
Ridgeback Capital Management
Cdib Capital International
8VC
DEFTA Partners

Funding info provided by Diffbot.